Stock Price Forecast

April 19, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Quanterix Corp chart...

About the Company

We do not have any company description for Quanterix Corp at the moment.

Exchange

Nasdaq

$122M

Total Revenue

401

Employees

$602M

Market Capitalization

-18.25

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $QTRX News

Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript

1mon ago, source: InvestingChannel on MSN

Quanterix Corporation isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the ...

Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance

1mon ago, source: Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX) today announced that it has rescheduled the release of its financial results for the fourth quarter and year ended December ...

Quanterix’s Strong IP Position Fuels Buy Rating in Alzheimer’s Diagnostic Market

24d ago, source: Business Insider

Begin your TipRanks Premium journey today. Quanterix (QTRX) Company Description: Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that ...

Quanterix Asserts Tau Patent Claims as AD Testing Market Heats Up, but IP Defensibility a Question

9d ago, source: 360dx

During an investor call, the firm said its patent covers high-sensitivity tau blood testing regardless of the platform used, but an IP expert questioned its claims.

Items Tagged with 'Quanterix Corp.'

1mon ago, source: BioWorld

Neurocode USA Inc. added Alzpath Dx, a blood test for Alzheimer’s disease screening, to its lab developed tests, making it the first available for commercial use in the U.S. The move stands to make ...

Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure

29d ago, source: Morningstar

Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced a specific partnership path for laboratories ...

Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier

25d ago, source: Anadolu Ajansi

--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has entered ...

Investing in Quanterix (NASDAQ:QTRX) a year ago would have delivered you a 111% gain

19d ago, source:

Quanterix Corporation ( NASDAQ:QTRX ) shareholders might be concerned after seeing the share price drop 13% in the ...

Devon Energy Corp DVN

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure

1mon ago, source: Stockhouse

Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced a specific partnership path for laboratories interested ...

Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure

1mon ago, source: Yahoo Finance

BILLERICA, Mass., March 21, 2024--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced a ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...